1. Home
  2. OFLX vs AVXL Comparison

OFLX vs AVXL Comparison

Compare OFLX & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omega Flex Inc.

OFLX

Omega Flex Inc.

HOLD

Current Price

$27.85

Market Cap

366.4M

Sector

Industrials

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$4.37

Market Cap

397.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OFLX
AVXL
Founded
1975
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
366.4M
397.6M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
OFLX
AVXL
Price
$27.85
$4.37
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$22.00
AVG Volume (30 Days)
33.6K
4.6M
Earning Date
10-29-2025
11-25-2025
Dividend Yield
4.90%
N/A
EPS Growth
N/A
N/A
EPS
1.59
N/A
Revenue
$100,054,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.42
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.58
$2.86
52 Week High
$48.58
$14.44

Technical Indicators

Market Signals
Indicator
OFLX
AVXL
Relative Strength Index (RSI) 49.36 40.02
Support Level $26.84 $3.62
Resistance Level $29.43 $4.84
Average True Range (ATR) 1.00 0.42
MACD 0.28 0.23
Stochastic Oscillator 52.21 74.53

Price Performance

Historical Comparison
OFLX
AVXL

About OFLX Omega Flex Inc.

Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: